切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - HIV Integrases - Flk1 - Cathepsins - Voltage-gated Potassium (KV) Channels

19件产品中的 1-10

页面
每页
清除全部
  1. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  2. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  5. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  6. Odanacatib (MK-0822)
    A2487 Odanacatib (MK-0822)
    中文名: 奥当卡替
    Target: Cathepsins
    Summary: 组织蛋白酶K抑制剂
      ≥17.7 mg/mL
      insoluble in H2O
  7. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  8. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B抑制剂
      ≥19.88 mg/mL
      insoluble in H2O
  9. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: 人组织蛋白酶L抑制剂
      <26.98 mg/mL
      <5.4 mg/mL
  10. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain和cathepsin B抑制剂
      ≥16.75 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页